XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.57

+0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (8372)	1/19/1999 11:55:00 AM
From: aknahow	Read Replies (1) of 17367

Bluegrass, you are correct, I can't explain the situation so everyone understands it. Nor do I see anything that wrong in the approach. Remember no one thought there would be a lot of accruals. Going with deaths is like saying even if you accrue a number of subjects that normally would not permit us to pass judgment on your drug we will pass judgement on it when mortality reaches X even though accruals still have not reached a significant level. This could speed rather than delay a decision. At any rate, I don't even see the skating on thin ice. Plans and goals slip, and one does not end up in court because everything does not go according to plan. BTW from your post you owned XOMA prior to the trials and after it became apparent that they would be continued. How can you seriously say you would not have invested in XOMA if the trial had been planned as a 3 year trial?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next